| Literature DB >> 26515620 |
Teerin Liewluck1, David S Saperstein2.
Abstract
Progressive muscular atrophy (PMA) is a rare, sporadic, adult-onset motor neuron disease, clinically characterized by isolated lower motor neuron features; however, clinically evident upper motor neuron signs may emerge in some patients. Subclinical upper motor neuron involvement is identified pathologically, radiologically, and neurophysiologically in a substantial number of patients with PMA. Patients with subclinical upper motor neuron involvement do not fulfill the revised El Escorial criteria to participate in amyotrophic lateral sclerosis clinical trials. Intravenous immunoglobulin therapy is only marginally beneficial in a small subgroup of patients with lower motor neuron syndrome without conduction block.Entities:
Keywords: Lower motor neuron syndrome; Lower motor neuron-onset ALS; PMA; Progressive muscular atrophy
Mesh:
Substances:
Year: 2015 PMID: 26515620 DOI: 10.1016/j.ncl.2015.07.005
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806